Wei Lin insider trades
Wei Lin has filed 12 Form 4s with the SEC that we hold, for Revolution Medicines, Inc. (RVMD) (Chief Medical Officer), TSVT (Director) and Erasca, Inc. (ERAS) (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 4 sales worth $600.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($206.2K). The largest single trade was a sale of 5,589 shares of Revolution Medicines, Inc. worth $209.0K, dated 2024-06-17. The first filing on our record is dated 2022-02-03 and the latest 2026-03-19.
Revolution Medicines, Inc. (RVMD)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-06-17 | S, sale reported on Form 4 | 5,589 | $209.0K | 2024-06-20 |
| 2025-06-16 | S, sale reported on Form 4 | 2,173 | $86.6K | 2025-06-18 |
| 2025-09-16 | S, sale reported on Form 4 | 2,160 | $99.0K | 2025-09-18 |
| 2026-03-17 | S, sale reported on Form 4 | 2,073 | $206.2K | 2026-03-19 |
TSVT
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Erasca, Inc. (ERAS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1872772) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms